LetibotulinumtoxinA is a newly registered neuromodulator for the treatment of glabellar lines in Europe.*,2 Its efficacy and safety was evaluated in three identical randomized, double-blind, placebo-controlled, multicenter, phase 3 studies including

This content is restricted to registered user. If you are an existing user, please log in. New users may register for free.

New User Registration
 
 
 
 
 
 
Please indicate that you agree to the Terms of Service *
*Required field